Novonesis (Novozymes) B (OCSE:NSIS B) Change In Inventory : kr0 Mil (TTM As of Mar. 2025)

View and export this data going back to 2000. Start your Free Trial

What is Novonesis (Novozymes) B Change In Inventory?

Novonesis (Novozymes) B's change in inventory for the quarter that ended in Mar. 2025 was kr0 Mil. It means Novonesis (Novozymes) B's inventory stayed the same from Dec. 2024 to Mar. 2025 .

Novonesis (Novozymes) B's change in inventory for the fiscal year that ended in Dec. 2024 was kr1,147 Mil. It means Novonesis (Novozymes) B's inventory declined by kr1,147 Mil from Dec. 2023 to Dec. 2024 .

Novonesis (Novozymes) B's Total Inventories for the quarter that ended in Mar. 2025 was kr5,447 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Novonesis (Novozymes) B's Days Inventory for the quarter that ended in Mar. 2025 was 136.96.

Inventory Turnover measures how fast the company turns over its inventory within a year. Novonesis (Novozymes) B's Inventory Turnover for the quarter that ended in Mar. 2025 was 0.67.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Novonesis (Novozymes) B's Inventory-to-Revenue for the quarter that ended in Mar. 2025 was 0.67.

Novonesis (Novozymes) B Change In Inventory Historical Data

The historical data trend for Novonesis (Novozymes) B's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novonesis (Novozymes) B Change In Inventory Chart

Novonesis (Novozymes) B Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Change In Inventory

Get a 7-Day Free Trial

180.96

-555.92

-785.80

137.89

1,146.99

Novonesis (Novozymes) B Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Dec24	Mar25
Change In Inventory	Get a 7-Day Free Trial															215.67	-	-	-	-

Novonesis (Novozymes) B Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0 Mil.

Novonesis (Novozymes) B (OCSE:NSIS B) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Novonesis (Novozymes) B's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	5410.5535	/	3604.791	*	365 / 4
	=	136.96

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Novonesis (Novozymes) B's Inventory Turnover for the quarter that ended in Mar. 2025 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	3604.791	/	5410.5535
	=	0.67

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Novonesis (Novozymes) B's Inventory to Revenue for the quarter that ended in Mar. 2025 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	5410.5535	/	8037.498
	=	0.67

Novonesis (Novozymes) B Change In Inventory Related Terms

Thank you for viewing the detailed overview of Novonesis (Novozymes) B's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Novonesis (Novozymes) B Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Novonesis (Novozymes) B (OCSE:NSIS B) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

NVZMY:USA NVZMF:USA NSISBc:UK 0Q4U:UK NZM:Germany NZM:Germany NZM2:Germany NZM2:Germany NZYM:Austria

Address

Krogshoejvej 36, Bagsvaerd, DNK, 2880

Website

https://www.novozymes.com

Novonesis was formed in 2024 through the merger of Novozymes and Chr. Hansen. Following the merger, the company became the world leader in industrial enzymes and microbial solutions, with a nearly 50% market share in both. The firm supplies a wide range of industry groups: household care, food and beverages, bioenergy, agriculture and feed, technical and pharmaceuticals. Its biological solutions create value for its customers by improving yield efficiency and performance, while saving energy and generating less waste. The company is headquartered in Denmark, employs around 10,000 people, and works across more than 30 research and development and application centers and 23 manufacturing sites.

Novonesis (Novozymes) B Headlines

No Headlines